{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:43:15Z","timestamp":1791193395942,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.bbr.2014.09.002","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T17:15:16Z","timestamp":1410023716000},"page":"114-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Place conditioning to apomorphine in rat models of Parkinson's disease: Differences by dose and side-effect expression"],"prefix":"10.1016","volume":"275","author":[{"given":"Joannalee C.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiveindra B.","family":"Jeyamohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla De La","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie G.","family":"Pilitsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbr.2014.09.002_bib0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2014.09.002_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00023210-200923020-00005","article-title":"Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management","volume":"23","author":"O\u2018Sullivan","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2014.09.002_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2012.04.027","article-title":"Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls","volume":"233","author":"Riddle","year":"2012","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.bbr.2014.09.002_bib0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ana.23881","article-title":"Levodopa gains psychostimulant-like properties after nigral dopaminergic loss","volume":"74","author":"Engeln","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2014.09.002_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuropharm.2012.12.011","article-title":"Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and L-dopa, in bilateral 6-OHDA-lesioned rat","volume":"70","author":"Zengin-Toktas","year":"2013","journal-title":"Neuropharmacology"},{"issue":"C","key":"10.1016\/j.bbr.2014.09.002_bib0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2013.05.042","article-title":"Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area","volume":"252","author":"Ouachikh","year":"2013","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.bbr.2014.09.002_bib0035","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Brit J Pharmacol"},{"issue":"2","key":"10.1016\/j.bbr.2014.09.002_bib0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","article-title":"Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"151","author":"Henry","year":"1998","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.bbr.2014.09.002_bib0045","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0091-3057(90)90559-Z","article-title":"Sensitization of rotation behavior in rats with unilateral 6-hydroxydopamine or kainic acid-induced striatal lesions","volume":"37","author":"Norman","year":"1990","journal-title":"Pharmacol Biochem Behav."},{"issue":"2","key":"10.1016\/j.bbr.2014.09.002_bib0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1152\/jn.00311.2012","article-title":"Deep brain stimulation of the substantia nigra pars reticulata improves forelimb akinesia in the hemiparkinsonian rat","volume":"109","author":"Sutton","year":"2013","journal-title":"J Neurophysiol"},{"issue":"5","key":"10.1016\/j.bbr.2014.09.002_bib0055","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.bbr.2014.09.002_bib0060","first-page":"647","article-title":"Neuropharmacological mechanisms of emesis II. Effects of antiemetic drugs on cisplatin-induced pica in rats","volume":"17","author":"Takeda","year":"1995","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.bbr.2014.09.002_bib0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0006-8993(83)91071-5","article-title":"Paradoxical reinforcing properties of apomorphine: effects of nucleus accumbens and area postrema lesions","author":"van der Kooy","year":"1983","journal-title":"Brain Res"},{"issue":"4233","key":"10.1016\/j.bbr.2014.09.002_bib0070","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1126\/science.1257748","article-title":"Both positive reinforcement and conditioned aversion from amphetamine and from apomorphine in rats","volume":"191","author":"Wise","year":"1976","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbr.2014.09.002_bib0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/FBP.0b013e3280144ac9","article-title":"Runway self-administration of intracerebroventricular cocaine: evidence of mixed positive and negative drug actions","volume":"18","author":"Guzman","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2014.09.002_bib0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuroscience.2012.05.052","article-title":"L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease","volume":"218","author":"Eskow Jaunarajs","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2014.09.002_bib0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fnsys.2013.00095","article-title":"Decomposition of abnormal free locomotor behavior in a rat model of Parkinson's disease","volume":"7","author":"Grieb","year":"2013","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.bbr.2014.09.002_bib0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1326-8-14","article-title":"Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits","volume":"8","author":"Carvalho","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bbr.2014.09.002_bib0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fneur.2014.00095","article-title":"Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies","volume":"5","author":"Finlay","year":"2014","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.bbr.2014.09.002_bib0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur J Neurosci"},{"issue":"Suppl 2","key":"10.1016\/j.bbr.2014.09.002_bib0105","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.parkreldis.2008.04.023","article-title":"Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence","volume":"14","author":"Carta","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1016\/j.bbr.2014.09.002_bib0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbr.2003.10.009","article-title":"Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias","volume":"152","author":"Delfino","year":"2004","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.bbr.2014.09.002_bib0115","doi-asserted-by":"crossref","first-page":"e60537","DOI":"10.1371\/journal.pone.0060537","article-title":"Why can\u2019t rodents vomit? A comparative behavioral, anatomical, and physiological study","volume":"8","author":"Horn","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814005853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814005853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T00:58:39Z","timestamp":1538269119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432814005853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":23,"alternative-id":["S0166432814005853"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2014.09.002","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Place conditioning to apomorphine in rat models of Parkinson's disease: Differences by dose and side-effect expression","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2014.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}